This opportunity uses the U01 Research Project – Cooperative Agreements funding mechanism.
This announcement solicits applications that will advance understanding of vaccine regimens and immune responses that sustainably suppress virus in HIV-infected individuals.
Funding will be made available to support small, multi-arm, comparative clinical trials designed to identify correlations between levels of induced immune response and HIV virologic control.
Vaccines may be combined with adjuvants and/or other modifiers of the immune response to HIV.
Funding & Duration
The scope of the proposed project should determine the project period. The maximum project period is 5 years.
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Submission Requirements & Due Dates
- 13 August 2018 – Letter of Intent (LOI) via Grants.Gov submission portal.
- 13 September 2018 – full applications submitted for internal review.
- Please email firstname.lastname@example.org if you are considering applying for this scheme.
- See also: Submitting an Application to Research Services for Review